Current evidence, competing explanations and tests of the chloride-apelin hypothesis.
| Proposed relationship | Current evidence | Interpretation and principal limitation | Suggested test required to resolve uncertainty |
|---|---|---|---|
| Chloride status and impaired decongestive response | Human observational cohorts and post hoc treatment analyses associate serum and urinary chloride with diuretic response and residual congestion [7, 8, 15–18]. | Reproducible association, but causal inference remains limited. Urine chloride is strongly correlated with urine sodium, and treatment was not randomised according to chloride status. | Prospective confirmation that serum or urinary chloride provides incremental information beyond urine sodium, diuretic exposure, kidney function and residual congestion. |
| Intracellular chloride and WNK-dependent transport | Structural and cellular studies show that chloride directly inhibits WNK1 activation and that intracellular chloride modifies WNK4-dependent sodium–chloride cotransporter activity [19, 20]. | Strong mechanistic evidence for chloride-sensitive WNK signalling, but no direct evidence that circulating chloride reflects this pathway in HF. | Compartment-specific and isosmotic chloride manipulation in human renal models, with direct measurement of WNK-SPAK/OSR1 activity and sodium-chloride transport. |
| Apelin and renal salt and water handling | Human kidney localisation, experimental animal physiology and a small randomised crossover study support renal apelin activity [9, 11, 21, 26]. | Direct evidence of acute renal responsiveness to apelin in humans, but no evidence that the response depends on chloride status or generalises to congested HF. | Controlled apelin administration in HF with serial serum and urinary chloride, sodium, renal haemodynamic and decongestive measurements. |
| Electrolyte/osmotic state and APJ regulation | Rat studies show altered central APJ expression after salt loading or water deprivation, while human apelin responses remain preserved during acute sodium depletion and angiotensin II exposure [24, 25]. | The apelin system is osmotically responsive, but no study isolates chloride-specific APJ regulation in human kidney or myocardium. | Isosmotic chloride manipulation that holds sodium, osmolality, pH, and potassium constant while directly measuring agonist-induced APJ signalling. |
| Renin-angiotensin signalling and apelin biology | Experimental studies support reciprocal regulation between the renin-angiotensin and apelin systems, while controlled human studies found preserved apelin responses during acute sodium depletion and angiotensin II exposure [22–24]. | Experimental evidence supports biological interaction, but acute human renin-angiotensin activation did not attenuate apelin responsiveness. Chronic state dependence remains untested. | Longitudinal human phenotyping and chronic disease-relevant models measuring chloride status, renin-angiotensin activity and ligand-responsive apelin-receptor signalling. |
| Myocardial load and apelin-receptor signalling context | Experimental mechanosignalling studies and human myocardial expression studies link APJ biology with mechanical stress and advanced HF [12, 26]. | Direct experimental evidence that stretch can activate APJ-related signalling, but human evidence concerns myocardial expression rather than agonist responsiveness. | Stretch-controlled human cardiomyocyte experiments with direct measurement of agonist-induced Gαi and β-arrestin signalling. |
| Hypoalbuminaemia and loop-diuretic response | Hypoalbuminaemia can alter loop-diuretic pharmacokinetics, and albumin-furosemide co-administration has shown heterogeneous short-term diuretic effects across hypoalbuminaemic populations [38, 39]. | A competing determinant of apparent diuretic resistance rather than evidence for chloride biology. Direct endogenous albumin-APJ interaction is unproven [40]. | Measure albumin prospectively, account for it in the clinical interaction model, and avoid attributing albumin-related pharmacokinetic resistance to chloride. |
| Combined chloride status and myocardial load modify apelin responsiveness | No direct evidence. | Central hypothesis of this Perspective. | Require replicated clinical interaction, chloride-specific mechanistic directionality and a human agonist-by-state interaction before clinical efficacy trials. |
APJ: apelin receptor; Gαi: inhibitory G-protein alpha subunit i; HF: heart failure; NCC: sodium–chloride cotransporter; NKCC2: sodium–potassium–chloride cotransporter 2; OSR1: oxidative stress-responsive kinase 1; SPAK: STE20/SPS1-related proline/alanine-rich kinase; WNK: with-no-lysine kinase.